![Sara Zaknoen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sara Zaknoen
Directeur/Membre du Conseil chez
ATYR PHARMA, INC.
Fortune : 3 582 $ au 30/06/2026
Profil
Sara L.
Zaknoen is currently an Independent Director at aTyr Pharma, Inc. since 2021.
Former roles include Medical Director at the University of Cincinnati (Ohio), Executive Director-Clinical Oncology Research at Novartis Pharmaceuticals Corp., Director-Experimental Therapeutics at The Western Pennsylvania Hospital, Director-Clinical Oncology Research at Schering-Plough Research Institute from 1998 to 2002, Chief Medical Officer at Cabrellis Pharmaceuticals Corp., Chief Medical Officer at Adastra Pharmaceuticals, Inc. from 2007 to 2012, Assistant Professor at the University of Cincinnati Medical Center, Chief Medical Officer at Ignyta, Inc. in 2014, and Chief Medical Officer at Polynoma LLC.
Education includes a doctorate from Indiana University and an undergraduate degree from Valparaiso University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ATYR PHARMA, INC. 0,01 % | 11/05/2026 | 6 000 ( 0,01 % ) | 3 582 $ | 30/06/2026 |
Postes actifs de Sara Zaknoen
| Sociétés | Poste | Début |
|---|---|---|
| ATYR PHARMA, INC. | Directeur/Membre du Conseil | 25/05/2021 |
Anciens postes connus de Sara Zaknoen
| Sociétés | Poste | Fin |
|---|---|---|
| IGNYTA INC | Directeur Technique/Scientifique/R&D | 28/04/2014 |
Adastra Pharmaceuticals, Inc.
 Adastra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides clinical and commercial development of proprietary drugs | Directeur Technique/Scientifique/R&D | - |
Cabrellis Pharmaceuticals Corp.
 Cabrellis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops therapies for the treatment of cancer | Directeur Technique/Scientifique/R&D | - |
Schering-Plough Research Institute
 Schering-Plough Research Institute Medical SpecialtiesHealth Technology Provides pharmaceutical research | Corporate Officer/Principal | 02/01/2002 |
University of Cincinnati Medical Center
 University of Cincinnati Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Formation de Sara Zaknoen
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
33
Relations au 1er degré
12
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
aTyr Pharma, Inc.
 aTyr Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a bio therapeutics company that discovers and develops medicines based on novel biological pathways | Health Technology |
Cabrellis Pharmaceuticals Corp.
Cabrellis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops therapies for the treatment of cancer | Health Technology |
Adastra Pharmaceuticals, Inc.
Adastra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides clinical and commercial development of proprietary drugs | Health Technology |
Indiana University
 Indiana University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Cincinnati (Ohio)
 University of Cincinnati (Ohio) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Valparaiso University
 Valparaiso University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
The Western Pennsylvania Hospital
 The Western Pennsylvania Hospital Medical/Nursing ServicesHealth Services Provides clinical and health related services | Health Services |
Schering-Plough Research Institute
Schering-Plough Research Institute Medical SpecialtiesHealth Technology Provides pharmaceutical research | Health Technology |
Polynoma LLC
 Polynoma LLC Pharmaceuticals: MajorHealth Technology Operates as an immuno-oncology company that develops a novel vaccine for the adjuvant treatment of stage IIB and IIC melanoma | Health Technology |
Ignyta, Inc.
 Ignyta, Inc. BiotechnologyHealth Technology Operates as a medicine biotechnology company which provides new drugs services for cancer patients | Health Technology |
University of Cincinnati Medical Center
University of Cincinnati Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
